Geode Capital Management, LLC Seelos Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.16 - $1.64 $7,171 - $73,506	44,821 Added 3.84%	1,211,726 $218,000
Q2 2023 Aug 11, 2023	BUY	$0.66 - $1.22 $19,076 - $35,262	28,904 Added 2.54%	1,166,905 $1.4 Million
Q1 2023 May 15, 2023	BUY	$0.59 - $1.04 $13,049 - $23,002	22,118 Added 1.98%	1,138,001 $785,000
Q4 2022 Feb 13, 2023	BUY	$0.66 - $1.34 $5,315 - $10,792	8,054 Added 0.73%	1,115,883 $757,000
Q3 2022 Nov 14, 2022	BUY	$0.65 - $1.41 $69,050 - $149,787	106,232 Added 10.61%	1,107,829 $1.14 Million

Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $314,216 - $572,982	-616,110 Reduced 38.09%	1,001,597 $681,000
Q1 2022 May 13, 2022	BUY	$0.84 - $1.71 $27,483 - $55,949	32,719 Added 2.06%	1,617,707 $1.36 Million
Q4 2021 Feb 11, 2022	SELL	$1.59 - $2.38 $217,335 - $325,319	-136,689 Reduced 7.94%	1,584,988 $2.58 Million
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $610,137 - $1.04 Million	361,028 Added 26.53%	1,721,677 $4.15 Million
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $2.16 Million - $5.17 Million	817,695 Added 150.6%	1,360,649 $3.59 Million
Q1 2021 May 12, 2021	BUY	$1.35 - $4.99 $312,303 - $1.15 Million	231,336 Added 74.24%	542,954 $2.71 Million
Q4 2020 Feb 12, 2021	BUY	$0.74 - $2.01 $116,343 - $316,014	157,221 Added 101.83%	311,618 $492,000
Q4 2019 Feb 13, 2020	BUY	$0.72 - $1.52 $496 - $1,048	690 Added 0.45%	154,397 $206,000
Q2 2019 Aug 14, 2019	BUY	$2.11 - $3.3 $242,922 - $379,925	115,129 Added 298.43%	153,707 $336,000
Q1 2019 May 14, 2019	SELL	$1.45 - $8.1 $275,265 - $1.54 Million	-189,838 Reduced 83.11%	38,578 $129,000
Q4 2018 Feb 13, 2019	BUY	$5.7 - $11.7 $1.3 Million - $2.67 Million	228,416 New	228,416 $43,000

Others Institutions Holding SEEL

# of Institutions

Shares Held

40.5K

Call Options Held

Put Options Held

Asset Management Corp

40.5K
Shares

$22,680
0.02% of portfolio

View Full List

About SEELOS THERAPEUTICS, INC.

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $59.7M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

More about SEEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account